NCT01283516 · Interventional trial
A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase
Overall registry status Completed
Phase 1
Conditions Tumors Characterized by Genetic Abnormalities of ALK
Delaware Valley sites
- Fox Chase Cancer Center Fox Chase Cancer (2) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory